Now available: AI Scribe & Transcription — clinical notes that write themselves.See it in action →
PlatformAI ScribePricingSpecialtiesBlogSupport
ICD-10-CM category

T46: Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system

285 subcodes · 198 billable · Look up any code with the ICD-10 search

Codes under T46 (Poisoning by, adverse effect of and underdosing of agents primarily affecting the cardiovascular system). A ✓ marks a billable (fully specified) code; category codes without a ✓ are not billable on their own.

CodeDescriptionBillable
T46.0Poisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
T46.0XPoisoning by, adverse effect of and underdosing of cardiac-stimulant glycosides and drugs of similar action
T46.0X1Poisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional)
T46.0X1APoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), initial encounter
T46.0X1DPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), subsequent encounter
T46.0X1SPoisoning by cardiac-stimulant glycosides and drugs of similar action, accidental (unintentional), sequela
T46.0X2Poisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm
T46.0X2APoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, initial encounter
T46.0X2DPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, subsequent encounter
T46.0X2SPoisoning by cardiac-stimulant glycosides and drugs of similar action, intentional self-harm, sequela
T46.0X3Poisoning by cardiac-stimulant glycosides and drugs of similar action, assault
T46.0X3APoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, initial encounter
T46.0X3DPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, subsequent encounter
T46.0X3SPoisoning by cardiac-stimulant glycosides and drugs of similar action, assault, sequela
T46.0X4Poisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined
T46.0X4APoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, initial encounter
T46.0X4DPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, subsequent encounter
T46.0X4SPoisoning by cardiac-stimulant glycosides and drugs of similar action, undetermined, sequela
T46.0X5Adverse effect of cardiac-stimulant glycosides and drugs of similar action
T46.0X5AAdverse effect of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T46.0X5DAdverse effect of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T46.0X5SAdverse effect of cardiac-stimulant glycosides and drugs of similar action, sequela
T46.0X6Underdosing of cardiac-stimulant glycosides and drugs of similar action
T46.0X6AUnderdosing of cardiac-stimulant glycosides and drugs of similar action, initial encounter
T46.0X6DUnderdosing of cardiac-stimulant glycosides and drugs of similar action, subsequent encounter
T46.0X6SUnderdosing of cardiac-stimulant glycosides and drugs of similar action, sequela
T46.1Poisoning by, adverse effect of and underdosing of calcium-channel blockers
T46.1XPoisoning by, adverse effect of and underdosing of calcium-channel blockers
T46.1X1Poisoning by calcium-channel blockers, accidental (unintentional)
T46.1X1APoisoning by calcium-channel blockers, accidental (unintentional), initial encounter
T46.1X1DPoisoning by calcium-channel blockers, accidental (unintentional), subsequent encounter
T46.1X1SPoisoning by calcium-channel blockers, accidental (unintentional), sequela
T46.1X2Poisoning by calcium-channel blockers, intentional self-harm
T46.1X2APoisoning by calcium-channel blockers, intentional self-harm, initial encounter
T46.1X2DPoisoning by calcium-channel blockers, intentional self-harm, subsequent encounter
T46.1X2SPoisoning by calcium-channel blockers, intentional self-harm, sequela
T46.1X3Poisoning by calcium-channel blockers, assault
T46.1X3APoisoning by calcium-channel blockers, assault, initial encounter
T46.1X3DPoisoning by calcium-channel blockers, assault, subsequent encounter
T46.1X3SPoisoning by calcium-channel blockers, assault, sequela
T46.1X4Poisoning by calcium-channel blockers, undetermined
T46.1X4APoisoning by calcium-channel blockers, undetermined, initial encounter
T46.1X4DPoisoning by calcium-channel blockers, undetermined, subsequent encounter
T46.1X4SPoisoning by calcium-channel blockers, undetermined, sequela
T46.1X5Adverse effect of calcium-channel blockers
T46.1X5AAdverse effect of calcium-channel blockers, initial encounter
T46.1X5DAdverse effect of calcium-channel blockers, subsequent encounter
T46.1X5SAdverse effect of calcium-channel blockers, sequela
T46.1X6Underdosing of calcium-channel blockers
T46.1X6AUnderdosing of calcium-channel blockers, initial encounter
T46.1X6DUnderdosing of calcium-channel blockers, subsequent encounter
T46.1X6SUnderdosing of calcium-channel blockers, sequela
T46.2Poisoning by, adverse effect of and underdosing of other antidysrhythmic drugs, not elsewhere classified
T46.2XPoisoning by, adverse effect of and underdosing of other antidysrhythmic drugs
T46.2X1Poisoning by other antidysrhythmic drugs, accidental (unintentional)
T46.2X1APoisoning by other antidysrhythmic drugs, accidental (unintentional), initial encounter
T46.2X1DPoisoning by other antidysrhythmic drugs, accidental (unintentional), subsequent encounter
T46.2X1SPoisoning by other antidysrhythmic drugs, accidental (unintentional), sequela
T46.2X2Poisoning by other antidysrhythmic drugs, intentional self-harm
T46.2X2APoisoning by other antidysrhythmic drugs, intentional self-harm, initial encounter
T46.2X2DPoisoning by other antidysrhythmic drugs, intentional self-harm, subsequent encounter
T46.2X2SPoisoning by other antidysrhythmic drugs, intentional self-harm, sequela
T46.2X3Poisoning by other antidysrhythmic drugs, assault
T46.2X3APoisoning by other antidysrhythmic drugs, assault, initial encounter
T46.2X3DPoisoning by other antidysrhythmic drugs, assault, subsequent encounter
T46.2X3SPoisoning by other antidysrhythmic drugs, assault, sequela
T46.2X4Poisoning by other antidysrhythmic drugs, undetermined
T46.2X4APoisoning by other antidysrhythmic drugs, undetermined, initial encounter
T46.2X4DPoisoning by other antidysrhythmic drugs, undetermined, subsequent encounter
T46.2X4SPoisoning by other antidysrhythmic drugs, undetermined, sequela
T46.2X5Adverse effect of other antidysrhythmic drugs
T46.2X5AAdverse effect of other antidysrhythmic drugs, initial encounter
T46.2X5DAdverse effect of other antidysrhythmic drugs, subsequent encounter
T46.2X5SAdverse effect of other antidysrhythmic drugs, sequela
T46.2X6Underdosing of other antidysrhythmic drugs
T46.2X6AUnderdosing of other antidysrhythmic drugs, initial encounter
T46.2X6DUnderdosing of other antidysrhythmic drugs, subsequent encounter
T46.2X6SUnderdosing of other antidysrhythmic drugs, sequela
T46.3Poisoning by, adverse effect of and underdosing of coronary vasodilators
T46.3XPoisoning by, adverse effect of and underdosing of coronary vasodilators
T46.3X1Poisoning by coronary vasodilators, accidental (unintentional)
T46.3X1APoisoning by coronary vasodilators, accidental (unintentional), initial encounter
T46.3X1DPoisoning by coronary vasodilators, accidental (unintentional), subsequent encounter
T46.3X1SPoisoning by coronary vasodilators, accidental (unintentional), sequela
T46.3X2Poisoning by coronary vasodilators, intentional self-harm
T46.3X2APoisoning by coronary vasodilators, intentional self-harm, initial encounter
T46.3X2DPoisoning by coronary vasodilators, intentional self-harm, subsequent encounter
T46.3X2SPoisoning by coronary vasodilators, intentional self-harm, sequela
T46.3X3Poisoning by coronary vasodilators, assault
T46.3X3APoisoning by coronary vasodilators, assault, initial encounter
T46.3X3DPoisoning by coronary vasodilators, assault, subsequent encounter
T46.3X3SPoisoning by coronary vasodilators, assault, sequela
T46.3X4Poisoning by coronary vasodilators, undetermined
T46.3X4APoisoning by coronary vasodilators, undetermined, initial encounter
T46.3X4DPoisoning by coronary vasodilators, undetermined, subsequent encounter
T46.3X4SPoisoning by coronary vasodilators, undetermined, sequela
T46.3X5Adverse effect of coronary vasodilators
T46.3X5AAdverse effect of coronary vasodilators, initial encounter
T46.3X5DAdverse effect of coronary vasodilators, subsequent encounter
T46.3X5SAdverse effect of coronary vasodilators, sequela
T46.3X6Underdosing of coronary vasodilators
T46.3X6AUnderdosing of coronary vasodilators, initial encounter
T46.3X6DUnderdosing of coronary vasodilators, subsequent encounter
T46.3X6SUnderdosing of coronary vasodilators, sequela
T46.4Poisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
T46.4XPoisoning by, adverse effect of and underdosing of angiotensin-converting-enzyme inhibitors
T46.4X1Poisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional)
T46.4X1APoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), initial encounter
T46.4X1DPoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), subsequent encounter
T46.4X1SPoisoning by angiotensin-converting-enzyme inhibitors, accidental (unintentional), sequela
T46.4X2Poisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm
T46.4X2APoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, initial encounter
T46.4X2DPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, subsequent encounter
T46.4X2SPoisoning by angiotensin-converting-enzyme inhibitors, intentional self-harm, sequela
T46.4X3Poisoning by angiotensin-converting-enzyme inhibitors, assault
T46.4X3APoisoning by angiotensin-converting-enzyme inhibitors, assault, initial encounter
T46.4X3DPoisoning by angiotensin-converting-enzyme inhibitors, assault, subsequent encounter
T46.4X3SPoisoning by angiotensin-converting-enzyme inhibitors, assault, sequela
T46.4X4Poisoning by angiotensin-converting-enzyme inhibitors, undetermined
T46.4X4APoisoning by angiotensin-converting-enzyme inhibitors, undetermined, initial encounter
T46.4X4DPoisoning by angiotensin-converting-enzyme inhibitors, undetermined, subsequent encounter
T46.4X4SPoisoning by angiotensin-converting-enzyme inhibitors, undetermined, sequela
T46.4X5Adverse effect of angiotensin-converting-enzyme inhibitors
T46.4X5AAdverse effect of angiotensin-converting-enzyme inhibitors, initial encounter
T46.4X5DAdverse effect of angiotensin-converting-enzyme inhibitors, subsequent encounter
T46.4X5SAdverse effect of angiotensin-converting-enzyme inhibitors, sequela
T46.4X6Underdosing of angiotensin-converting-enzyme inhibitors
T46.4X6AUnderdosing of angiotensin-converting-enzyme inhibitors, initial encounter
T46.4X6DUnderdosing of angiotensin-converting-enzyme inhibitors, subsequent encounter
T46.4X6SUnderdosing of angiotensin-converting-enzyme inhibitors, sequela
T46.5Poisoning by, adverse effect of and underdosing of other antihypertensive drugs
T46.5XPoisoning by, adverse effect of and underdosing of other antihypertensive drugs
T46.5X1Poisoning by other antihypertensive drugs, accidental (unintentional)
T46.5X1APoisoning by other antihypertensive drugs, accidental (unintentional), initial encounter
T46.5X1DPoisoning by other antihypertensive drugs, accidental (unintentional), subsequent encounter
T46.5X1SPoisoning by other antihypertensive drugs, accidental (unintentional), sequela
T46.5X2Poisoning by other antihypertensive drugs, intentional self-harm
T46.5X2APoisoning by other antihypertensive drugs, intentional self-harm, initial encounter
T46.5X2DPoisoning by other antihypertensive drugs, intentional self-harm, subsequent encounter
T46.5X2SPoisoning by other antihypertensive drugs, intentional self-harm, sequela
T46.5X3Poisoning by other antihypertensive drugs, assault
T46.5X3APoisoning by other antihypertensive drugs, assault, initial encounter
T46.5X3DPoisoning by other antihypertensive drugs, assault, subsequent encounter
T46.5X3SPoisoning by other antihypertensive drugs, assault, sequela
T46.5X4Poisoning by other antihypertensive drugs, undetermined
T46.5X4APoisoning by other antihypertensive drugs, undetermined, initial encounter
T46.5X4DPoisoning by other antihypertensive drugs, undetermined, subsequent encounter
T46.5X4SPoisoning by other antihypertensive drugs, undetermined, sequela
T46.5X5Adverse effect of other antihypertensive drugs
T46.5X5AAdverse effect of other antihypertensive drugs, initial encounter
T46.5X5DAdverse effect of other antihypertensive drugs, subsequent encounter
T46.5X5SAdverse effect of other antihypertensive drugs, sequela
T46.5X6Underdosing of other antihypertensive drugs
T46.5X6AUnderdosing of other antihypertensive drugs, initial encounter
T46.5X6DUnderdosing of other antihypertensive drugs, subsequent encounter
T46.5X6SUnderdosing of other antihypertensive drugs, sequela
T46.6Poisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
T46.6XPoisoning by, adverse effect of and underdosing of antihyperlipidemic and antiarteriosclerotic drugs
T46.6X1Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional)
T46.6X1APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), initial encounter
T46.6X1DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), subsequent encounter
T46.6X1SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, accidental (unintentional), sequela
T46.6X2Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm
T46.6X2APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, initial encounter
T46.6X2DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, subsequent encounter
T46.6X2SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, intentional self-harm, sequela
T46.6X3Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault
T46.6X3APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, initial encounter
T46.6X3DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, subsequent encounter
T46.6X3SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, assault, sequela
T46.6X4Poisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined
T46.6X4APoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, initial encounter
T46.6X4DPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, subsequent encounter
T46.6X4SPoisoning by antihyperlipidemic and antiarteriosclerotic drugs, undetermined, sequela
T46.6X5Adverse effect of antihyperlipidemic and antiarteriosclerotic drugs
T46.6X5AAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
T46.6X5DAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
T46.6X5SAdverse effect of antihyperlipidemic and antiarteriosclerotic drugs, sequela
T46.6X6Underdosing of antihyperlipidemic and antiarteriosclerotic drugs
T46.6X6AUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, initial encounter
T46.6X6DUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, subsequent encounter
T46.6X6SUnderdosing of antihyperlipidemic and antiarteriosclerotic drugs, sequela
T46.7Poisoning by, adverse effect of and underdosing of peripheral vasodilators
T46.7XPoisoning by, adverse effect of and underdosing of peripheral vasodilators
T46.7X1Poisoning by peripheral vasodilators, accidental (unintentional)
T46.7X1APoisoning by peripheral vasodilators, accidental (unintentional), initial encounter
T46.7X1DPoisoning by peripheral vasodilators, accidental (unintentional), subsequent encounter
T46.7X1SPoisoning by peripheral vasodilators, accidental (unintentional), sequela
T46.7X2Poisoning by peripheral vasodilators, intentional self-harm
T46.7X2APoisoning by peripheral vasodilators, intentional self-harm, initial encounter
T46.7X2DPoisoning by peripheral vasodilators, intentional self-harm, subsequent encounter
T46.7X2SPoisoning by peripheral vasodilators, intentional self-harm, sequela
T46.7X3Poisoning by peripheral vasodilators, assault
T46.7X3APoisoning by peripheral vasodilators, assault, initial encounter
T46.7X3DPoisoning by peripheral vasodilators, assault, subsequent encounter
T46.7X3SPoisoning by peripheral vasodilators, assault, sequela
T46.7X4Poisoning by peripheral vasodilators, undetermined
T46.7X4APoisoning by peripheral vasodilators, undetermined, initial encounter
T46.7X4DPoisoning by peripheral vasodilators, undetermined, subsequent encounter
T46.7X4SPoisoning by peripheral vasodilators, undetermined, sequela
T46.7X5Adverse effect of peripheral vasodilators
T46.7X5AAdverse effect of peripheral vasodilators, initial encounter
T46.7X5DAdverse effect of peripheral vasodilators, subsequent encounter
T46.7X5SAdverse effect of peripheral vasodilators, sequela
T46.7X6Underdosing of peripheral vasodilators
T46.7X6AUnderdosing of peripheral vasodilators, initial encounter
T46.7X6DUnderdosing of peripheral vasodilators, subsequent encounter
T46.7X6SUnderdosing of peripheral vasodilators, sequela
T46.8Poisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
T46.8XPoisoning by, adverse effect of and underdosing of antivaricose drugs, including sclerosing agents
T46.8X1Poisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional)
T46.8X1APoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), initial encounter
T46.8X1DPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), subsequent encounter
T46.8X1SPoisoning by antivaricose drugs, including sclerosing agents, accidental (unintentional), sequela
T46.8X2Poisoning by antivaricose drugs, including sclerosing agents, intentional self-harm
T46.8X2APoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, initial encounter
T46.8X2DPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, subsequent encounter
T46.8X2SPoisoning by antivaricose drugs, including sclerosing agents, intentional self-harm, sequela
T46.8X3Poisoning by antivaricose drugs, including sclerosing agents, assault
T46.8X3APoisoning by antivaricose drugs, including sclerosing agents, assault, initial encounter
T46.8X3DPoisoning by antivaricose drugs, including sclerosing agents, assault, subsequent encounter
T46.8X3SPoisoning by antivaricose drugs, including sclerosing agents, assault, sequela
T46.8X4Poisoning by antivaricose drugs, including sclerosing agents, undetermined
T46.8X4APoisoning by antivaricose drugs, including sclerosing agents, undetermined, initial encounter
T46.8X4DPoisoning by antivaricose drugs, including sclerosing agents, undetermined, subsequent encounter
T46.8X4SPoisoning by antivaricose drugs, including sclerosing agents, undetermined, sequela
T46.8X5Adverse effect of antivaricose drugs, including sclerosing agents
T46.8X5AAdverse effect of antivaricose drugs, including sclerosing agents, initial encounter
T46.8X5DAdverse effect of antivaricose drugs, including sclerosing agents, subsequent encounter
T46.8X5SAdverse effect of antivaricose drugs, including sclerosing agents, sequela
T46.8X6Underdosing of antivaricose drugs, including sclerosing agents
T46.8X6AUnderdosing of antivaricose drugs, including sclerosing agents, initial encounter
T46.8X6DUnderdosing of antivaricose drugs, including sclerosing agents, subsequent encounter
T46.8X6SUnderdosing of antivaricose drugs, including sclerosing agents, sequela
T46.9Poisoning by, adverse effect of and underdosing of other and unspecified agents primarily affecting the cardiovascular system
T46.90Poisoning by, adverse effect of and underdosing of unspecified agents primarily affecting the cardiovascular system
T46.99Poisoning by, adverse effect of and underdosing of other agents primarily affecting the cardiovascular system
T46.901Poisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional)
T46.901APoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46.901DPoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
T46.901SPoisoning by unspecified agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
T46.902Poisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm
T46.902APoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46.902DPoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
T46.902SPoisoning by unspecified agents primarily affecting the cardiovascular system, intentional self-harm, sequela
T46.903Poisoning by unspecified agents primarily affecting the cardiovascular system, assault
T46.903APoisoning by unspecified agents primarily affecting the cardiovascular system, assault, initial encounter
T46.903DPoisoning by unspecified agents primarily affecting the cardiovascular system, assault, subsequent encounter
T46.903SPoisoning by unspecified agents primarily affecting the cardiovascular system, assault, sequela
T46.904Poisoning by unspecified agents primarily affecting the cardiovascular system, undetermined
T46.904APoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46.904DPoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
T46.904SPoisoning by unspecified agents primarily affecting the cardiovascular system, undetermined, sequela
T46.905Adverse effect of unspecified agents primarily affecting the cardiovascular system
T46.905AAdverse effect of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46.905DAdverse effect of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
T46.905SAdverse effect of unspecified agents primarily affecting the cardiovascular system, sequela
T46.906Underdosing of unspecified agents primarily affecting the cardiovascular system
T46.906AUnderdosing of unspecified agents primarily affecting the cardiovascular system, initial encounter
T46.906DUnderdosing of unspecified agents primarily affecting the cardiovascular system, subsequent encounter
T46.906SUnderdosing of unspecified agents primarily affecting the cardiovascular system, sequela
T46.991Poisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional)
T46.991APoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), initial encounter
T46.991DPoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), subsequent encounter
T46.991SPoisoning by other agents primarily affecting the cardiovascular system, accidental (unintentional), sequela
T46.992Poisoning by other agents primarily affecting the cardiovascular system, intentional self-harm
T46.992APoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, initial encounter
T46.992DPoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, subsequent encounter
T46.992SPoisoning by other agents primarily affecting the cardiovascular system, intentional self-harm, sequela
T46.993Poisoning by other agents primarily affecting the cardiovascular system, assault
T46.993APoisoning by other agents primarily affecting the cardiovascular system, assault, initial encounter
T46.993DPoisoning by other agents primarily affecting the cardiovascular system, assault, subsequent encounter
T46.993SPoisoning by other agents primarily affecting the cardiovascular system, assault, sequela
T46.994Poisoning by other agents primarily affecting the cardiovascular system, undetermined
T46.994APoisoning by other agents primarily affecting the cardiovascular system, undetermined, initial encounter
T46.994DPoisoning by other agents primarily affecting the cardiovascular system, undetermined, subsequent encounter
T46.994SPoisoning by other agents primarily affecting the cardiovascular system, undetermined, sequela
T46.995Adverse effect of other agents primarily affecting the cardiovascular system
T46.995AAdverse effect of other agents primarily affecting the cardiovascular system, initial encounter
T46.995DAdverse effect of other agents primarily affecting the cardiovascular system, subsequent encounter
T46.995SAdverse effect of other agents primarily affecting the cardiovascular system, sequela
T46.996Underdosing of other agents primarily affecting the cardiovascular system
T46.996AUnderdosing of other agents primarily affecting the cardiovascular system, initial encounter
T46.996DUnderdosing of other agents primarily affecting the cardiovascular system, subsequent encounter
T46.996SUnderdosing of other agents primarily affecting the cardiovascular system, sequela

More free billing tools: all ICD-10 categories · ICD-10 search · denial codes · Medicare fees

Informational only, not coding or medical advice. Verify against the official ICD-10-CM (FY2026) and your payer's guidelines.

Code the diagnosis right

Join providers across the country delivering modern virtual care with CareNiva. Free to start, ready in minutes.

100% Satisfaction Guaranteed — try it risk-free